2015 Review and Outlook: Digging in for the Long Haul

The biopharma industry enters 2015 with a dramatically more complex business reality, fueled by greater competition, newly empowered payers and a drug development pipeline that has shifted into a higher gear. In our annual Review and Outlook, we set forth what companies need to know when recruiting CEOs, board members and key functional executives to lead in this new environment.